Xiao Liang

机构：Beike Biotechnology (China) · ORCID：0000-0003-3266-5018

发表论文 27 篇 · 总被引 314 次 · h-index 10

代表论文

• A first in-human study of A166 in patients with locally advanced/metastatic solid tumors which are HER2-positive or HER2-amplified who did not respond or stopped responding to approved therapies. (2020 · Journal of Clinical Oncology · 被引 50)
• Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer (2021 · Journal of Cancer · 被引 41)
• Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer (2021 · Medicine · 被引 40)
• Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage (2021 · Stem Cell Research & Therapy · 被引 31)
• Treatment Strategies for Metastatic Gastric Cancer: Chemotherapy, Palliative Surgery or Radiotherapy? (2019 · Future Oncology · 被引 29)
• Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression (2023 · Cell Death and Disease · 被引 24)